Skip to main content
. 2020 Jun 18;14:1651–1663. doi: 10.2147/OPTH.S258081

Table 3.

Results of Primary and Secondary Endpoints for Evaporative (EDE) and Non-Evaporative Dry Eye (NEDE) Groups

EDE Group (N=54) NEDE Group (N=18)
Endpoints Total Mean±SD P§ Total Mean±SD P§
VSE CTN VSE CTN
TBUT (sec)
 Baseline 3.3±1.6 3.3±1.6 2.9±1.1 2.9±1.2
 Intermediate visit 4.6±1.8 4.6±1.8** 4.6±1.8** 0.08 4.1±2.4 4.1±2.4* 4.1±2.4* 0.29
 Final visit 6.0±2.8 5.6±2.4** 6.5±2.8** 0.74 4.6±2.4 4.6±2.3* 4.6±2.6* 0.30
OSDI questionnaire score
 Baseline 39±13 39±13 32±8 32±8
 Intermediate visit 24±15 24±15** 24±15** 0.44 20±15 20±15* 20±15* 0.46
 Final visit 20±13 20±15** 20±15** 0.38 18±12 18±11** 18±14* 0.49
Schirmer I test (mm/5 min)
 Baseline 16±5 16±5 16±6 16±6
 Intermediate visit 16±8 16±8 16±8 0.38 14±9 14±9 14±9 0.44
 Final visit 14±9 15±9 14±9 0.34 16±10 17±11 16±10 0.40
Complete blinkings (N/min)
 Baseline 16±13 16±13 9±5 9±5
 Intermediate visit 19±10 19±10 19±10 0.43 11±8 11±8 11±8 0.46
 Final visit 22±18 20±15 25±21 0.81 8±5 7±4 9±6 0.77
Incomplete blinkings (N/min)
 Baseline 7±6 7±6 11±9 11±9
 Intermediate visit 5±5 5±5 5±5 0.37 3±3 3±3* 3±3* 0.40
 Final visit 3±4 4±5 2±2** 0.005 3±4** 5±4* 1±2 0.04
Total blinkings (N/min)
 Baseline 23±12 23±12 20±13 20±13
 Intermediate visit 24±13 24±13 24±13 0.45 13±7 13±7 13±7 0.45
 Final visit 25±17 24±15 27±20 0.68 11±6** 13±6* 10±6** 0.22
Osmolarity (mOsm/L)
 Baseline 313±20 313±20 318±30 318±30
 Intermediate visit 309±15 309±15 309±15 0.47 296±17 296±17 296±17 0.48
 Final visit 305±15 307±14 303±17 0.26 308±23 299±18 318±26 0.85

Notes: §Paired T-test to compare two treatment group, adjusting by baseline value. *T-test vs baseline, p<0.05. **T-test vs baseline, p<0.001.

Abbreviations: CTN, Cationorm; VSE, VisuEvo.